Kutaja Indienne

Kutaja contains alkaloids, primarily conessine, which demonstrate anti-amoebic activity against Entamoeba histolytica. The active compounds (conessine, kurchicine, holarrhimine) work by inhibiting amoebic growth and reducing intestinal inflammation. Traditional Ayurvedic use suggests it also helps restore healthy gut mucosa and normalizes bowel function. Evidence Level: C (preliminary clinical evidence).

Kutaja (Holarrhena antidysenterica) is primarily used in Ayurveda for treating amoebic dysentery, chronic diarrhea, and intestinal parasites. It is considered one of the most effective herbs for amoebic infections. Additional traditional uses include managing irritable bowel syndrome (IBS) and promoting overall digestive health. The bark is the primary medicinal part used. Evidence Level: C/Traditional.

The traditional Ayurvedic dosage for Kutaja bark is 1-3 grams of powder or as a decoction, taken 2-3 times daily for adults. This is typically prepared as a tea or mixed with water. Duration of use should be guided by a qualified practitioner, as long-term safety data is limited. For chronic conditions like IBS, consult an Ayurvedic practitioner for personalized dosing. Evidence Level: Traditional/C.

Kutaja is contraindicated during pregnancy and breastfeeding. The alkaloids present, particularly conessine, may stimulate uterine contractions and pose risks to fetal development. Traditional Ayurvedic texts explicitly advise against use during pregnancy. Women who are pregnant, planning pregnancy, or nursing should avoid Kutaja entirely. Evidence Level: C/Traditional.

Limited research exists on Kutaja drug interactions. Theoretically, due to its effects on the gastrointestinal tract, it may alter absorption of oral medications. Patients taking antidiarrheal medications, antibiotics for parasitic infections, or drugs requiring precise dosing should consult a healthcare provider before combining with Kutaja. Always disclose herbal supplement use to your healthcare provider. Evidence Level: C.